Outline

● Background
● General Guidelines
● Specific Guidelines
● Roles and Responsibilities
 Outline

Background
 Continuous rise
of susceptible
population to
Vaccine
Preventable
Diseases
(VPDs).

Source: FHSIS Reports and partial 2021 data

 ALL regions
have measles cases
● Majority of cases are in NCR
and Region 4A

● Most are 6-59 months old that

are unvaccinated or with
unknown vaccination status
● 66% are 6-59
months old

● 75% were either

unvaccinated or
unknown
vaccination
status

*Data needs further

cleaning
OUTBREAK is IMMINENT

1. Huge susceptible
cohort
2. Increased mobility
3. Poor surveillance
 Outline

General Guidelines
1. Whole-society and
whole-of-government approach
for simultaneous COVID and
non-COVID vaccination
- Private sectors and
government hospitals may
partner with CHDs for service
delivery and/or demand
generation
2. Conducted every last Thursdays and Fridays for the months of April - June.
Target: At least 80% per antigen for the remaining 2021 target and 2022 target

MONDAY TUESDAY WEDNESDAY THURSDAY FRIDAY

Routine NIP; Routine NIP; Routine NIP; Routine NIP; Routine NIP;
Week 1 COVID-19 vaxx COVID-19 vaxx COVID-19 vaxx COVID-19 vaxx COVID-19 vaxx
Microplanning
Routine NIP; Routine NIP; Routine NIP; Routine NIP; Routine NIP;
Week 2 for NVD
COVID-19 vaxx COVID-19 vaxx COVID-19 vaxx COVID-19 vaxx COVID-19 vaxx

Routine NIP; Routine NIP; Routine NIP; Routine NIP; Routine NIP;
Week 3 COVID-19 vaxx COVID-19 vaxx COVID-19 vaxx COVID-19 vaxx COVID-19 vaxx

Final Final Routine NIP; NVD for Routine NVD for Routine
Preparations Preparations COVID-19 vaxx
Week 4 and Catch-up and Catch-up
Immunization Immunization
 APRIL MAY-JUNE

P/CWHS with more than 10k missed children Nationwide

1. Cavite 19. City of Manila
2. Laguna 20. Leyte
3. Batangas 21. Masbate
4. Rizal 22. Cagayan
5. Bulacan 23. Oriental Mindoro
6. Cebu 24. Pampanga
7. Negros Occidental 25. Bohol
8. Camarines Sur 26. Quezon City
9. Iloilo 27. Caloocan
10. North Cotabato 28. Isabela
11. Pangasinan 29. Albay
12. South Cotabato 30. Sorsogon
13. Quezon 31. Bukidnon
14.Palawan 32. Zambales
15. Nueva Ecija 33. Northern Samar
16. Zamboanga del Sur 34. Misamis Oriental
17. Davao del Sur 35. Occidental Mindoro
18. Negros Oriental 36. Samar (Western Samar)

Department of Health, Philippines

3. Moratorium on COVID 19-vaccination and other program activities for the
2-days of NVD-CI.

4. Eligible population is all 0-23 months old infants who missed a dose,
doses or series of vaccines which can be identified through the defaulter list.

5. All catch-up antigens identified in AO 2021-0045 shall be utilized.

6. Ensure that all antigens that may be given as catch-up antigens shall be
administered at first contact with the succeeding doses, if applicable, given
at least 4 weeks interval between doses.
7. Minimum Public Health
Standards (MPHS) at all times
during NVD-CI.

8. Reporting done immediately

or within one week after each
monthly NVD-CI.
- IClinicSys
- FHSIS TCL
 Outline

Specific Guidelines
 NVD-CI Targets
At least 80% per antigen shall be covered for the remaining 2021 and 2022 eligible
population. This shall be set by the CHDs per region, provincial and RHU/HF level.
Example MCV1 Antigen in NCR:

Age Group Formula EP 80% Target per Ag

2021 0-12 General formula: 75,422

months old NVD-CI EP(Ag) = 2021 eligible pop - 2021 (Ag) coverage children Target per Ag (80%) =
remaining Example:
EP x 0.8
target NVD-CI EP (MCV1) = 2021 Eligible pop - 2021 MCV1 Coverage

NVD-CI target = 235,298 - 159,856 60,338 0-23

NVD-CI Target = 75, 422
months old
children*

EP - Eligible Population
Ag - Antigen

*+/- 10% since actual targets will still

include a few of 2020 missed targets
and 2022 target
 NVD-CI Targets
● CHDs in coordination with LGUs shall set the daily targets for other
vaccination sites, ensuring that it is equally distributed to both health facilities
and other vaccination sites.

● Technical assistance shall be provided to LGUs by the DPCB-NIP and CHDs

such as:
○ Conduct of microplanning
○ Augmentation of resources including HRH
○ Funding

*+/- 10% since actual targets will still

include a few of 2020 missed targets
Allocation and Distribution of Vaccines
DPCB - FSCMD

RITM-SDD (vaccines) SCMS (ancillaries)

CHDs

P/CHOs

LGUs Other vaccination sites

 Social Mobilization, Advocacy and Communication

HPB COM HEPOs and social

mobilizers
● Develop campaign plans ● Organize briefing and ● Dissemination of
that will utilize all means advocacy meetings w/ information and materials
of information channels different stakeholders such as specific
and platforms ● Develop crisis schedules and specific
communication plans for sites
the NVDs-CI ● Conduct of advocacy
meetings w/ barangay
leaders

Link to IEC materials:

https://bit.ly/CBD_RI_CI2022
 Vaccination Preparation and Process
Pre-NVD CI Preparation Checklist: Volunteers
○ Vaccinators: Health
Defaulter list professionals (medical
○ prepared at least 2 weeks doctors, nurses, midwives,
○ disseminated to vaccination fourth year nursing students
teams and vaccination sites at and PGIs/Clinical clerks with
least 1 week supervision)
○ Health educators: Other allied
Dissemination of information for health professionals including
NVD-CI through various media undergraduates
platforms and information systems ○ Data encoders
 Registration, Screening, Health Education and
Vaccination
● LGU shall check the following at the registration area:
○ Previous vaccination card of infants
○ Proof of parents/guardians’ leave

● Vaccination process including health screening, health education, vaccination

process and AEFI monitoring shall follow NIP Manual of Procedures
 Registration, Screening, Health Education and
Vaccination

Fixed Sites Modified Fixed Post Door-to-door

Integrated and packaged with other health services especially in far-flung

and hard to reach areas.
 1st visit > 6 wks u to > 10 wks up > 14 wks to 9 mos up to 12 mos up NOTE
10 wks to 14 wks less than 9 less than 12 to 23 mos
mos mos
Guide to Defaulter A: OPV, PENTA, OPV, PENTA, OPV, PENTA, MCV1, IPV2 MCV2 Ensure at
Defaulter PCV (1st
dose)
PCV
(2nd dose)
PCV (3rd dose)
and IPV1
least 4
weeks

Vaccines interval in
between
doses;
Defaulter B: OPV, PENTA, OPV, PENTA, OPV, PENTA, MCV (2nd
If 9 mos, give
PCV (1st PCV PCV (3rd dose)
MCV1
dose) (2nd dose) and dose)
IPV (1st dose) IPV (2nd
dose) and
Check
MCV (1st
immunizatio
dose)
n history, if
OPV, PENTA, given prior
Defaulter C OPV, PENTA, OPV, doses,
PCV(2nd
PCV (1st dose) PENTA, PCV proceed with
dose);
(3rd dose) the next dose
IPV and
IPV and in the series.
MCV (1st
MCV (2nd
dose)
dose)

Defaulter D OPV,
PENTA,
PCV, MCV1
and IPV1
(1st dose)
 Vaccination Teams

Health Screener/ Vaccinators Vaccination Team Data Encoder

Educator Supervisor

Each vaccination team is expected to vaccinate 80-100 infants/day

 Logistics and Cold Chain Management
● Each RHU/BHS/HFs shall have a designated vaccination team
supervisor:
○ Ensure that vaccine and vaccine ancillaries are available, conditioned
and monitored
○ Monitor and record the temperature in the vaccine refrigerator and
carriers
○ Test all electrical equipment to avoid vaccine quality reduction
 Data Reporting

Submission of Recording/Updating
Aggregated Data of Child Records
Gsheet: TCL or IClinicSys
https://tinyurl.com/
Catch-Up2022
Done every end of Done a week after
the day for NVD-CI NVD-CI
Data Encoders
 Monitoring and Supervision

● Vaccination team supervisor shall accomplish the following tasks every

NVD-CI:
○ Ensure adequate resources including Health Human Resources for
Health, vaccine logistics, ancillaries and other commodities
○ Ensure submission of data by data encoders at RHU/BHS/HF

● DPCB and CHDs shall analyze data coverage for the NVD-CI on a monthly
basis
○ Feedback for the performances of LGUs
○ Provide assistance for identified low-performing areas
 Surveillance and AEFI Reporting
● All detected AEFIs, may it be classified as minor or major, shall be reported
to the nearest health facility. For this purpose, the existing AO 2016-0006
entitled, ‘Revised Guidelines and Response to Adverse Events Following
Immunization’ shall be followed.

● Following AO 2016-0025: entitled ‘Guidelines on the Referral System for

Adverse Events,’ AEFI cases needing intensive care and hospitalization shall
be managed and referred to the appropriate health facility.
 Outline

Roles and Responsibilities

 CHDs and MOH-BARMM
● Conduct orientation and planning meeting for concerned stakeholders regarding the policy and
advocate for its adoption and implementation;
● Provide technical assistance and capacity building to LGUs and other partners on the catch-up
immunization services;
● Harmonize other partners to solicit support for immunization program;
● Ensure intensification of health promotions regarding catch-up immunization services together with
routine immunization services within their area of influence;
● Conduct analysis of data from Local Government Units and submit timely reports using the FHSIS
reporting tool;
● Evaluate and monitor the implementation of the policy by both public and private sectors in their
respective regions; and
● Conduct random data quality checks on submitted reports by the LGUs.
● Formalize formed partnerships between CHDs and professional institutions, private sector and
other supporting stakeholders through a memorandum of agreement.
 Local Government Units
● Conduct of catch-up immunization services within their area of influence in accordance to the
guidelines set by DOH;
● Ensure the supply of vaccines in their areas of jurisdiction by continuously monitoring vaccines
supply, utilizing the current stocks their area have and requesting stock from the next higher level;
● Allocate vaccine supplies and commodities to other partner stakeholders that will provide
immunization services during the NVD-CI based on predetermined targets for each respective
immunization service partners.
● Provide localized support or counterpart (i.e. resources, collaterals, others) for the implementation
of the policy;
● Develop strategies for conduct of catch-up immunization specific to their area of jurisdiction;
● Conduct regular consultation and implementation reviews among respective LGU personnel,
immunization stakeholders, and other organizational partners to improve service delivery efficiency
and address implementation issues/gaps; and
● Submit timely reports to the DOH for monitoring and tracking of progress of implementation.